Master Protocol for Metastatic Hormone-Resistant Prostatic Carcinoma Phase II Trials Protocol 4: Vinorelbine.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Vinorelbine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 26 Jun 2019 Biomarkers information updated
- 28 Feb 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00003259), additional centres and investigators added as reported by ClinicalTrials.gov.
- 28 Feb 2011 Last checked against ClinicalTrials.gov record.